Pfizer to Take \$369 Mln Asbestos Charge  NEW YORK (Reuters) - Pfizer Inc. &lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=PFE.N target=/stocks/quickinfo/fullquote"&gt;PFE.N&lt;/A&gt; on Friday said it  would take a third-quarter pretax charge of \$369 million for a  settlement with plaintiffs who allege they were harmed by  products containing asbestos and other minerals once sold by a  Pfizer subsidiary.